Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Indian Rupee Strengthens Past 96 Per Dollar as RBI Intervention Eases Pressure CPF LIFE as a Retirement Anchor How Stable Payouts Can Support Essential Expenses SpaceX Scrubs Starship Test Flight Eyes Friday Retry Amid IPO Preparations Ferrari Faces Backlash Over First Electric Vehicle The 550000 Luce Sparks Traditionalist Fury Inflation Pressures Intensify Ahead of Memorial Day Weekend as Prices Surge for Travel Food and Fuel Evolus Inc EOLS Q1 2026 Earnings EPS Surprises to the Upside Amid Stock Decline AMPY Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges XPEL Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure PGY Q1 2026 Earnings EPS Surges 263 Above Estimates Amid Strong Performance ZION Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Omitted ASTLW Surges Nearly 30 but Remains at Critical SupportResistance Level Anteris Technologies Global Corp AVR Surges 489 Key Levels to Watch Morgan Stanley India Investment Fund IIF Rallies 135 as Emerging Market Sentiment Improves Costamare Inc CMRE Shares Slide Over 4 Key Support Levels in Focus Pokmon Card Market Surges on Nostalgia Speculation and HighProfile Sales Global Markets Edge Higher as USIran Talks Offer Fragile Calm Oil Holds Above 100 Bandus Blockbusters Market Speculation in Focus as May 24 Deadline Approaches Enhanced Games Set to Debut in Las Vegas as Donald Trump Jr and Peter Thiel Back Steroid Olympics Venture UAN Q1 2026 Earnings Strong EPS of 472 Driven by Favorable Nitrogen Market Units Dip Slightly GASS Q4 2025 Earnings EPS Beat of 417 Highlights Operational Efficiency Amid Market Headwinds TIL Q1 2026 Earnings WiderthanExpected Loss Highlights EarlyStage Development Challenges AGNCN Q1 2026 Earnings EPS Surpasses Estimates by 145 WEBTOON Entertainment Inc WBTN Q1 2026 Earnings EPS Beat Surprises Market but Stock Slips CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase